ID
14626
Description
Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00387907
Link
https://clinicaltrials.gov/show/NCT00387907
Keywords
Versions (1)
- 4/24/16 4/24/16 -
Uploaded on
April 24, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Breast Cancer NCT00387907
Eligibility Advanced Breast Cancer NCT00387907
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
heart condition
Data type
boolean
Alias
- UMLS CUI [1]
- C3842523
Description
pregnant women
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
history of another cancer
Data type
boolean
Alias
- UMLS CUI [1]
- C1512706
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Similar models
Eligibility Advanced Breast Cancer NCT00387907
- StudyEvent: Eligibility
C0232804 (UMLS CUI [2])